Hua Naranmandura serves an Associate Professor at the Institute of Pharmacology, Toxicology, and Biochemical Pharmaceutics, College of Pharmaceutical Sciences at Zhejiang University, China. Dr. Naranmandura received his M.S. and Ph.D. degrees in pharmacology and toxicology in 2005 and 2008, respectively, from Chiba University (Japan), where he studied toxicology of drug and arsenic. Then, he completed his postdoctoral work at the University of Alberta (Canada), where he studied the cellular and molecular mechanisms of acquired tolerance to metal toxicity and metal speciation. He is currently focusing on several topics, including: (1) arsenic speciation, exposure, metabolism, and health effects; (2) the molecular mechanisms of the carcinogenic effects of arsenicals (e.g., thioarsenicals) and its metabolism; (3) the role of AS3MT (expression, genotypes, etc.) in human hepatocytes and leukemia cells; (4) the effect of arsenic intermediate metabolites on PML/RARA oncoprotein in NB4 cells.
Biography Updated on 11 December 2011